Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
Last trade$49.97
Day change+$0.30 (+0.60%)
Day range$48.75 – $52.50
Volume290,472
Market cap$988M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$987.53M
Price / earnings
36.03×
Price / book
2.34×
Price / sales
1.83×
EV / sales
1.91×
EV / EBITDA
15.16×
Profitability
Earnings per share
$1.38
Return on assets
3.24%
Return on equity
6.48%
Dividend yield
0.63%
Liquidity and leverage
Debt / equity
0.7×
Current ratio
5.83×
Quick ratio
4.13×
Cash ratio
3.06×
Cash flow
Price / cash flow
28.78×
Price / free cash flow
41.41×
Free cash flow
$23.85M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for TPB, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$151.1M
$142.96M
$124.28M
$121.01M
$118.98M
$116.63M
$106.44M
$93.67M
Cost of revenue
$65.92M
$49.26M
$55.98M
$53.36M
$48.55M
$50.01M
$46.83M
$41.25M
Gross profit
$85.18M
$93.7M
$68.3M
$67.65M
$70.43M
$66.62M
$59.61M
$52.42M
Selling, general and administrative
$75.31M
$76.99M
$55.81M
$47.73M
$44.54M
$40.3M
$36.42M
$34.53M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$75.31M
$76.99M
$55.81M
$47.73M
$44.54M
$40.3M
$36.42M
$36.21M
Operating income
$9.87M
$16.71M
$12.48M
$19.93M
$25.89M
$26.33M
$23.19M
$16.21M
Interest expense
-$4.24M
-$4.25M
-$4.42M
$0
-$3.53M
-$5.14M
-$4.41M
$0
Income before taxes
$8.26M
$13.98M
$11.13M
$13.88M
$30.23M
$21.2M
$17.83M
$14.48M
Income taxes
$1.41M
$3.68M
-$2.81M
$2.24M
$6.47M
$4.24M
$2.04M
$4.12M
Net income
$6.85M
$10.3M
$13.94M
$11.64M
$23.76M
$16.96M
$15.79M
$3.05M
Net income attributable to common shareholders
$3.93M
$3.6M
$11.67M
$8.21M
$21.08M
$14.48M
$14.4M
$2.42M
EBITDA
$13.05M
$18.46M
$14.54M
$21.94M
$28.4M
$27.6M
$24.81M
$17.78M
Basic earnings per share
$0.20
$0.18
$0.61
$0.43
$1.16
$0.81
$0.81
$0.13
Diluted earnings per share
$0.19
$0.18
$0.60
$0.42
$1.13
$0.79
$0.79
$0.13
Recent news
Company coverage with links to the original publishers.
Altria Group reported Q3 2026 smokeable segment adjusted OCI of $3.07B, up 3.9% year-over-year, with margins expanding to 64.5%. Strong pricing (4.4% price realization) and tax refunds offset declining cigarette shipments (-2.9%) and higher costs. Marlboro's premium share reached 60%, while the company faces ongoing industry headwinds from reduced cigarette demand.
Turning Point Brands reported Q3 2026 earnings of $0.41 per share, beating consensus estimates of $0.33, with revenues of $151.1 million exceeding expectations. However, the stock has underperformed the market by 39.2% year-to-date and carries a Zacks Rank #4 (Sell) rating due to unfavorable estimate revisions. The tobacco industry ranks in the bottom 25% of Zacks industries. Edgewell Personal Care is expected to report results on November 12 with anticipated earnings of $0.78 per share, though revenue is expected to decline 10.5% year-over-year.
Altria Group expanded its on! PLUS 12mg nicotine pouches nationwide in Q3 2026 across three flavors, capitalizing on growing demand for higher-strength products. Nicotine pouches now represent 61.2% of the oral tobacco category. However, Altria faces intensifying competition from Philip Morris' ZYN and Turning Point Brands' FRE and ALP products, which are also expanding their market presence with new variants and increased retail distribution.
Altria Group is focusing on its premium cigarette segment, which generates 85% of profitability, as consumers shift toward discount offerings. Marlboro maintained its 59.6% premium segment share but saw overall cigarette market share decline 1.5 points to 39.5%. The company is expanding its discount brand Basic to capture trade-down demand while protecting Marlboro pricing power, with smokeable adjusted OCI rising 2.4% to $3.02 billion.
Altria's on! PLUS nicotine pouch product is gaining early momentum with retail presence expanding to approximately 120,000 stores and encouraging repeat purchase rates. However, the company faces intensifying competition from Philip Morris's ZYN and Turning Point Brands's FRE and ALP products, which are also expanding aggressively in the U.S. nicotine pouch market. Altria's stock has underperformed the industry over the past three months, trading at a lower valuation multiple.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.08 per share
Declared
Nov 2, 2026
Ex-dividend
Dec 18, 2026
Pay date
Jan 8, 2027
Ex-dividend
Amount / share
Pay date
Type
Sep 18, 2026
$0.08
Oct 9, 2026
recurring
Jun 18, 2026
$0.08
Jul 10, 2026
recurring
Mar 20, 2026
$0.08
Apr 10, 2026
recurring
Dec 19, 2025
$0.075
Jan 9, 2026
recurring
Sep 19, 2025
$0.075
Oct 10, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.